Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants - NYT

While less effective than the Moderna and Pfizer vaccines, Johnson & Johnson’s is still considered a strong vaccine by scientists. Annual flu vaccines, for example, are typically 40 to 60 percent effective.